SCHEMBL19989982

SCHEMBL19989982

COC(=O)c1cc(-c2ccnc(F)c2F)cc2c1nc(C)n2-c1ccnc2c(F)cccc12

nearest known ligand 0.58

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PIK3R2 O00459 20/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19989818 0.91 PIK3R2 (0.68) PIK3R2
SCHEMBL19989802 0.91 PIK3R2 (0.64) PIK3R2
SCHEMBL19989822 0.90 PIK3R2 (0.71) PIK3R2
SCHEMBL19989919 0.88 PIK3R2 (0.69) PIK3R2
SCHEMBL19990060 0.88 PIK3R2 (0.57) PIK3R2
SCHEMBL19989967 0.88 PIK3R2 (0.56) PIK3R2
SCHEMBL19989892 0.87 PIK3R2 (0.64) PIK3R2
SCHEMBL19989776 0.86 PIK3R2 (0.56) PIK3R2
SCHEMBL19989809 0.84 PIK3R2 (0.61) PIK3R2
SCHEMBL19990059 0.83 PIK3R2 (0.64) PIK3R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10227350-B2 Phosphatidylinositol 3-kinase inhibitors GILEAD SCIENCES, INC. (US) 2019-03-12 US disclosed
US-20180086768-A1 PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS GILEAD SCIENCES, INC. 2018-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10227350-B2 Phosphatidylinositol 3-kinase inhibitors PIK3CA, AKT3, AKT1 PIK3R2 13/4885
US-20180086768-A1 PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS PIK3CA, AKT3, AKT1 PIK3R2 13/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.